SCHEMBL22453611

SCHEMBL22453611

CCNC(=O)c1ccccc1Nc1ccc(Nc2ccc(C34CC5CC(CC(C5)C3)C4)cc2Cl)cc1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ P2RX7 Q99572 6/20 0.43
▸ KMT2A Q03164 1/20 0.42
▸ GPR55 Q9Y2T6 1/20 0.42
▸ SERPINE1 P05121 2/20 0.41
▸ EPHX2 P34913 1/20 0.41
▸ PTK2 Q05397 1/20 0.41
▸ MAPK1 P28482 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ HIF1A Q16665 1/20 0.39
▸ EPAS1 Q99814 1/20 0.39
▸ CNR2 P34972 3/20 0.39
▸ MAPK13 O15264 1/20 0.39
▸ MAPK12 P53778 1/20 0.39
▸ MAPK11 Q15759 1/20 0.39
▸ MAPK14 Q16539 1/20 0.39
▸ CXCR2 P25025 1/20 0.39
▸ MT-CO2 P00403 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22453322 0.89 POLB (0.44) P2RX7SERPINE1EPHX2PTK2MAPK1
SCHEMBL22453029 0.89 EPHX2 (0.48) P2RX7KMT2AGPR55EPHX2PTK2
SCHEMBL22452486 0.86 HIF1A (0.50) P2RX7KMT2ASERPINE1EPHX2NPC1
SCHEMBL22453525 0.85 MAPT (0.50) KMT2AGPR55SERPINE1EPHX2NPC1
SCHEMBL22452762 0.85 SIRT2 (0.46) P2RX7SERPINE1EPHX2NPC1HIF1A
SCHEMBL22453612 0.84 P2RX7 (0.43) P2RX7KMT2AGPR55SERPINE1EPHX2
SCHEMBL31555349 0.80 SERPINE1 (0.51) KMT2ASERPINE1EPHX2NPC1HIF1A
SCHEMBL22453520 0.80 SERPINE1 (0.51) KMT2ASERPINE1EPHX2NPC1HIF1A
SCHEMBL22452789 0.80 SERPINE1 (0.61) KMT2ASERPINE1EPHX2NPC1HIF1A
SCHEMBL22452715 0.80 SERPINE1 (0.64) KMT2ASERPINE1EPHX2NPC1HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020190774-A1 NOVEL SMALL MOLECULE INHIBITORS OF TEAD TRANSCRIPTION FACTORS THE GENERAL HOSPITAL CORPORATION (US) 2020-09-24 — — WO disclosed
Send feedback